PHARMACOGENETICS OF INTRAVENOUS AND ORAL BUSULFAN IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

Kinetics-based dose targeting is often conducted in hematopoietic cell transplant (HCT) patients conditioned with intravenous (IV) or oral busulfan to lower rates of rejection, nonrelapse mortality, and relapse. Using the candidate gene approach, we evaluated whether busulfan clearance was associate...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Abbasi, Nissa, Vadnais, Barbara, Knutson, Jennifer A., Blough, David K., Kelly, Edward J., O’Donnell, Paul V., Deeg, H. Joachim, Pawlikowski, Matthew, Ho, Rodney J. Y., McCune, Jeannine S.
格式: Artigo
語言:Inglês
出版: 2010
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117932/
https://ncbi.nlm.nih.gov/pubmed/21135089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0091270010382915
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍